Skip to main content

Currently Skimming:

8 Recommendations
Pages 269-278

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 269...
... The two are clearly linked, but tackling the problems of service utilization would require another study. The committee recognizes that they have set a broad and ambitious agenda -- one that will require support and cooperation from a spectrum of participants, from Congress and federal agencies and regulatory agencies to physician organizations, the research community, and health care payers and providers.
From page 270...
... Comparative studies of screening programs indicate that programs with high rates of abnormal mammograms tend to have low positive predictive value for biopsies. Although these studies cannot determine the underlying causes of this trend, they highlight several characteristics of successful breast cancer screening programs in other countries that are not fully realized in the United States.
From page 271...
... A2. Breast imagers and technology developers should work in collabora tion with health care providers and payers to improve the overall quality of mammographic interpretation by: · Adopting and further developing practices that promote self-im provement of breast imagers, but that do not jeopardize the workforce.
From page 272...
... Although not widely appreciated and rarely practiced, it would in fact be permissible within the provisions of the MQSA to have nonphysician personnel examine mammograms -- as long as a certified physician signed the mammogram report indicating that he or she had interpreted it. This suggestion that physician extenders could be enlisted to help read mammograms could thus offer women a more thorough examination than is currently typical of most mammography facilities where mammograms are viewed only by a single breast imager.
From page 273...
... A variety of breast cancer risk factors have been identified, and they continue to be discovered, but it is still not possible to predict who will develop lethal breast cancer, and who will not. This imperfect knowledge informs a spectrum of important medical decisions along the pathway from breast cancer detection to treatment, in some cases involving extreme preventive measures such as bilateral mastectomy.
From page 274...
... Although basic research enables the development of early stage technologies, different strategies are needed to identify which technologies are truly feasible and add clinical value by improving health or the delivery of health care services. Large
From page 275...
... B3. Research funders, including the National Cancer Institute and private foundations, should develop tools that facilitate communication re garding breast cancer risk to the public and to health care providers.
From page 276...
... , advocacy groups, private health care payers, and provider organizations. · Experimentation with innovative organizational structures for the centers should be encouraged.
From page 277...
... · Advocacy groups and women's health organizations should par ticipate in design and execution of public education about clinical trials. This could be a collaborative effort, and might include the National Cancer Institute and the American Cancer Society.
From page 278...
... IMPROVE THE IMPLEMENTATION AND USE OF NEW TECHNOLOGIES D1. Breast cancer research funders, such as the National Institutes of Health, Department of Defense, and private foundations, should sup port research on screening and detection technologies that encom passes each aspect of technology adoption from deployment to appli cation, and should include monitoring of use in practice.


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.